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SUMMARY
The LPA gene is the only monogenetic risk factor for calcific aortic valve stenosis (CAVS). Oxidized phospholipids (OxPL) and lysophosphatidic acid generated by autotaxin (ATX) from OxPL are pro-inflammatory. Aortic valve leaflets categorized pathologically from both ATX-apolipoprotein B and ATX-apolipoprotein(a) were measureable in plasma. Lipoprotein(a) revealed 33% to 39% all-cause mortality, 12% to 19% rate of stroke, and 40% to 48% major adverse cardiac event rate at 3-year follow-up in both groups (3) .
Lipoprotein(a) (Lp [a] ) is a genetically determined, likely causal, and independent risk factor for the presence and progression of CAVS (4) (5) (6) (7) (8) . Lp(a) is the major lipoprotein carrier of phosphocholinecontaining oxidized phospholipids (PC-OxPLs) (9, 10) that may contribute to inflammation and induce calcification in valvular cells (11, 12) . For example, in the ASTRONOMER (Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin) trial (4), patients with elevated Lp(a) and OxPL on apolipoprotein B-100 (OxPL-apoB) levels had the fastest progression rate and higher need for AVR. Autotaxin (ATX), which breaks down lysophosphatidylcholine (LysoPC) derived from OxPL to lysophosphatidic acid (LysoPA), was also recently shown to be strongly associated with CAVS (13). In turn, because OxPL and oxidized low-density lipoprotein have been shown to be present in CAVS (13) (14) (15) , it is likely that a significant portion of the LysoPC is derived from hydrolysis of the truncated oxidized sn2 fatty acids found in OxPL present in oxidized low-density lipoprotein, which are generated by such enzymes as lipoprotein-associated phospholipase A 2 and platelet-activating factor acetylhydrolase. In recent findings, ATX activity and either Lp(a) or OxPL-apoB strongly interacted to predict the presence of CAVS in patients undergoing AVR with concomitant coronary artery disease (8) .
There are no effective medical therapies to prevent the development or progression of CAVS, and statins 
Torzewski et al. Values are median (min-max) or n (%). *Only 26 patients had available echocardiography data. †Only 36 patients had available echocardiography data.
CAVS ¼ calcific aortic valve stenosis; HbA1c ¼ glycosylated hemoglobin; hsCRP ¼ high-sensitivity C-reactive protein; LDL-C ¼ low-density lipoprotein cholesterol; NT-proBNP ¼ N-terminal pro-B-type natriuretic peptide. Torzewski et al. (26, 27) . With the use of the specific monoclonal antibody LPA4, apo(a) was detectable in every lesion examined.
Grade 1 lesions were characterized by a lack of calcified areas, and a predominant focal deposition of apo(a) was present in the fibrosa (Figure 3) . ATX, as well as OxPL epitopes, stained by antibody E06, were less evident but where present, they did co-localize with apo(a). MDA-lysine epitopes, stained by antibody MDA2, were diffusely present in the leaflet, but macrophages stained by antibody to CD68 were sparse.
Grade 2 lesions were characterized by early development of calcified nodules and a more prominent deposition of apo(a) in the fibrosa as well as in the spongiosa (Figure 4) . ATX was present in areas of apo(a) staining. OxPL epitopes as well as MDA-lysine epitopes were also more prominent than in grade 1 but less evident than apo(a). Sequential sections stained for calcification with alizarin red S and macrophages (CD68) (upper panel), apolipoprotein(a) (LPA4) and autotaxin (ATX) (middle panel) as well as oxidized phospholipids (EO6) and malondialdehyde epitopes (MDA2) (lower panel). Note the lack of calcified areas as well as the predominantly extracellular co-localization of the different antigens. In all panels, the aortic side of the valve is at the top.
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Sequential sections stained for alizarin red S and macrophages (CD68) (upper panel), apolipoprotein (a) (LPA4), and autotaxin (ATX) (middle panel), as well as oxidized phospholipids (EO6) and malondialdehyde epitopes (MDA2) (lower panel). Note the small calcified areas
(asterisks), the lack of CD68 staining in this individual lesion (high variation of macrophages staining in aortic valve sclerosis), as well as the predominantly extracellular co-localization of the different antigens. In all panels, the aortic side of the valve is at the top.
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Lp(a)-OxPL-ATX and CAVS . Sometimes additional intracellular oxidized phospholipid staining is also evident (arrowheads). In all panels, the aortic side of the valve is at the top.
Torzewski et al. LysoPA were particularly present in the most 
n represents the number of pathological grades analyzed within each category. Some of the leaflets harbored >1 different pathological grade, which is why the numbers analyzed are different from those of leaflets/patients. Torzewski et al.
OxPL, and areas of calcification in diseased aortic valve leaflets; and that its product, LysoPA, can be directly detected in valve leaflets from subjects with CAVS.
STUDY LIMITATIONS. This study included tissue and/or blood samples from 3 distinct populations, and therefore direct comparison of plasma levels of ATX-apoB and ATX-apo(a) with histological assessment of aortic valve apo(a), ATX content, and spectrophotometric quantitation of OxPL and LysoPA content was not feasible. Also, plasma levels of Lp(a)
were not available in patients undergoing AVR due to lack of prior evidence of its etiologic importance to correlate the plasma levels with histological findings. OxPL-apoB, and ATX with therapeutic agents may be a viable approach to prevent or reduce the rate of progression of CAVS.
